Monique Visser

Title: Monique Visser: Innovator in Immunotherapy and Women's Health

Introduction

Monique Visser is a notable inventor recognized for her contributions to the fields of immunotherapy and women's health. Her innovative work focuses on developing therapeutic methods for treating ovarian cancer and addressing hypertensive disorders during pregnancy. Despite having no patents to her name, her research has the potential to significantly impact medical treatments.

Latest Patents

Monique Visser's latest patents include an immunotherapeutic method for treating and/or preventing ovarian cancer. This invention relates to the use of immunogenic polypeptides derived from ovarian tissue cell-associated proteins, specifically zona pellucida glycoproteins. These polypeptides can induce a CD8+ and/or CD4+ T cell response, providing a promising avenue for immunotherapeutic strategies. Another significant patent involves the treatment or prevention of hypertensive disorders of pregnancy or fetal growth retardation. This invention utilizes steroids in pharmaceutical compositions aimed at addressing these critical health issues.

Career Highlights

Throughout her career, Monique Visser has worked with reputable companies such as Pantarhei Bioscience B.V. and Donesta Bioscience B.V. Her experience in these organizations has allowed her to contribute to groundbreaking research and development in her field.

Collaborations

Monique has collaborated with esteemed colleagues, including Herman Jan Coelingh Bennink and Herman Jan Tijmen Coelingh Bennink. These partnerships have fostered a collaborative environment that enhances innovation and research outcomes.

Conclusion

Monique Visser's work exemplifies the intersection of innovation and healthcare, particularly in the areas of immunotherapy and women's health. Her contributions, although not yet reflected in patents, hold significant promise for future medical advancements.